Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 262.93 USD 0.35% Market Closed
Market Cap: 18.4B USD
Have any thoughts about
Insulet Corp?
Write Note

Insulet Corp
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insulet Corp
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Insulet Corp
NASDAQ:PODD
Tax Provision
$124.2m
CAGR 3-Years
303%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Tax Provision
-$307m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Boston Scientific Corp
NYSE:BSX
Tax Provision
-$414m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Tax Provision
-$600m
CAGR 3-Years
-27%
CAGR 5-Years
-8%
CAGR 10-Years
-2%
Abbott Laboratories
NYSE:ABT
Tax Provision
-$1B
CAGR 3-Years
0%
CAGR 5-Years
-15%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Tax Provision
-$119.7m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
2%
No Stocks Found

Insulet Corp
Glance View

Market Cap
18.4B USD
Industry
Health Care

Insulet Corporation is a pioneering medical device company, primarily recognized for its innovative Omnipod Insulin Management System, which revolutionizes diabetes care. Founded in 2000, Insulet has focused on developing patch pump technology that offers a seamless, tubeless insulin delivery solution for individuals with insulin-dependent diabetes. This cutting-edge product allows users to manage their insulin delivery discreetly and conveniently, enhancing their quality of life and simplifying the complex regimen of diabetes management. As the prevalence of diabetes continues to rise globally, Insulet stands at the forefront of meeting a substantial medical need, capturing a significant market share with its user-friendly technology. As an investor, understanding Insulet’s growth trajectory and market potential is essential. The company has witnessed consistent revenue growth, driven by increased adoption of its Omnipod systems, and has expanded its product portfolio to include a new generation of devices that offer even greater functionality. Insulet is also heavily investing in research and development to further innovate its offerings, positioning itself competitively in the fast-evolving diabetes care market. With strong industry partnerships and a commitment to enhancing user experience, Insulet represents not just a promising investment in healthcare technology but also a company that is fundamentally improving the lives of millions.

PODD Intrinsic Value
96.69 USD
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Insulet Corp's Tax Provision?
Tax Provision
124.2m USD

Based on the financial report for Sep 30, 2024, Insulet Corp's Tax Provision amounts to 124.2m USD.

What is Insulet Corp's Tax Provision growth rate?
Tax Provision CAGR 3Y
303%

The average annual Tax Provision growth rates for Insulet Corp have been 303% over the past three years .

Back to Top